Post by
Spamme54321 on Jul 17, 2024 3:17pm
Volume low price action no good
Even the usual pumpers have given up.
I think EDT will not see any real appreciation with real volume until FDA approval (probably at least 1 year away).
Nobodies going to take Spectral over unless they get the greenlight from the FDA.
So it's currently in a binary situation.
Remember they already failed to get FDA greenlight a few years back and the market knows that.
So the market is in a wait and see mode.
Comment by
gebremeskel on Jul 17, 2024 10:04pm
I don't know - there's always the possibility that the Carlyle Group will scoop up Spectral once they've got Vantive. Something tells me they already know all they need to know about the chances of regulatory approval. And it's not like money will be an issue...